NTRA - Natera, Inc.

Insider Sale by Brophy Michael Burkes (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Brophy Michael Burkes, serving as CFO at Natera, Inc. (NTRA), sold 5,063 shares at $197.84 per share, for a total transaction value of $1,001,645.00. Following this transaction, Brophy Michael Burkes now holds 58,291 shares of NTRA.

This sale represents a 8.00% decrease in Brophy Michael Burkes's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 27, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 29, 2026, 2 days after the trade was made.

Natera, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Brophy Michael Burkes

Brophy Michael Burkes

CFO

Michael Burkes Brophy is the Chief Financial Officer of Natera Inc, a position he has held since February 2017[[7]](https://app.boardroomalpha.com/profiles/people/A1114986-MICHAEL_BURKES_BROPHY). He joined Natera in 2015 and has progressed through multiple leadership roles, including Vice President of Corporate Development and Investor Relations, and Senior Vice President of Finance and Investor Relations[[6]](https://www.natera.com/company/leadership-team/). Brophy holds an MBA[[6]](https://www.natera.com/company/leadership-team/) and currently oversees financial operations for the genomics-focused healthcare company based in Austin, Texas[[3]](https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-34c9a31d5277.html). As of March 2026, Brophy directly owns 63,354 shares of Natera stock[[2]](https://www.investing.com/news/insider-trading-news/natera-cfo-brophy-sells-160k-in-ntra-stock-93CH-4556022). His recent trading activity includes the receipt of 1,968 fully vested Restricted Stock Units on March 9, 2026, followed by a sale of 785 shares on March 10, 2026, at approximately $204.13 per share to cover tax obligations[[2]](https://www.investing.com/news/insider-trading-news/natera-cfo-brophy-sells-160k-in-ntra-stock-93CH-4556022)[[3]](https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-34c9a31d5277.html). Over the past five years, Brophy has made 88 transactions in Natera stock, with a focus on sales[[1]](https://www.gurufocus.com/insider/60403/michael-burkes-brophy). In 2023, his total compensation from Natera exceeded $5 million, including a base salary of $465,293 and significant stock awards[[1]](https://www.gurufocus.com/insider/60403/michael-burkes-brophy). Beyond his role at Natera, Brophy serves as a director at Health Sciences Acquisitions Corp 2 and Orchestra BioMed Holdings Inc[[1]](https://www.gurufocus.com/insider/60403/michael-burkes-brophy).

View full insider profile →

Trade Price

$197.84

Quantity

5,063

Total Value

$1,001,645.00

Shares Owned

58,291

Trade Date

Monday, April 27, 2026

4 days ago

SEC Filing Date

Wednesday, April 29, 2026

Filed 2 days after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

Discussion

Sign in to join the discussion.
Loading comments…
View news mentioning NTRA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/6057755

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime